Filatex India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 17, 2025, 8:48 pm

Competitors of Filatex India Ltd

All Competitor Stocks of Filatex India Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:30 pm

Below is a detailed analysis of the quarterly data for Filatex India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,049.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,080.00 Cr. (Mar 2025) to 1,049.00 Cr., marking a decrease of 31.00 Cr..
• For Expenses, as of Jun 2025, the value is 982.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,009.00 Cr. (Mar 2025) to 982.00 Cr., marking a decrease of 27.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 68.00 Cr.. The value appears to be declining and may need further review. It has decreased from 71.00 Cr. (Mar 2025) to 68.00 Cr., marking a decrease of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 6.00%. The value appears to be declining and may need further review. It has decreased from 7.00% (Mar 2025) to 6.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
• For Interest, as of Jun 2025, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2025) to 55.00 Cr., marking a decrease of 1.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
• For Net Profit, as of Jun 2025, the value is 41.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 41.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.92. The value appears to be declining and may need further review. It has decreased from 0.93 (Mar 2025) to 0.92, marking a decrease of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:24 am

Growth

Last Updated: September 5, 2025, 3:55 am

Balance Sheet

Last Updated: November 9, 2025, 1:59 pm

Below is a detailed analysis of the balance sheet data for Filatex India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 44.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,365.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,287.00 Cr. (Mar 2025) to 1,365.00 Cr., marking an increase of 78.00 Cr..
• For Borrowings, as of Sep 2025, the value is 141.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 147.00 Cr. (Mar 2025) to 141.00 Cr., marking a decrease of 6.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 858.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 798.00 Cr. (Mar 2025) to 858.00 Cr., marking an increase of 60.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,408.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,276.00 Cr. (Mar 2025) to 2,408.00 Cr., marking an increase of 132.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 1,318.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,324.00 Cr. (Mar 2025) to 1,318.00 Cr., marking a decrease of 6.00 Cr..
• For CWIP, as of Sep 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 6.00 Cr..
• For Investments, as of Sep 2025, the value is 338.00 Cr.. The value appears strong and on an upward trend. It has increased from 186.00 Cr. (Mar 2025) to 338.00 Cr., marking an increase of 152.00 Cr..
• For Other Assets, as of Sep 2025, the value is 733.00 Cr.. The value appears to be declining and may need further review. It has decreased from 754.00 Cr. (Mar 2025) to 733.00 Cr., marking a decrease of 21.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,408.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,276.00 Cr. (Mar 2025) to 2,408.00 Cr., marking an increase of 132.00 Cr..

Notably, the Reserves (1,365.00 Cr.) exceed the Borrowings (141.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Filatex India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 2.00 (Mar 19) to 1.00, marking a decrease of 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.02. This value is below the healthy minimum of 5. It has decreased from 3.90 (Mar 19) to 3.02, marking a decrease of 0.88.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 5. It has decreased from 3.83 (Mar 19) to 3.01, marking a decrease of 0.82.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.67. This value is within the healthy range. It has decreased from 5.97 (Mar 19) to 4.67, marking a decrease of 1.30.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.97. It has increased from 21.65 (Mar 19) to 29.97, marking an increase of 8.32.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.97. It has increased from 21.65 (Mar 19) to 29.97, marking an increase of 8.32.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 95.79. It has decreased from 132.14 (Mar 19) to 95.79, marking a decrease of 36.35.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.18. This value is within the healthy range. It has decreased from 10.50 (Mar 19) to 6.18, marking a decrease of 4.32.
• For PBIT / Share (Rs.), as of Mar 25, the value is 4.53. This value is within the healthy range. It has decreased from 8.44 (Mar 19) to 4.53, marking a decrease of 3.91.
• For PBT / Share (Rs.), as of Mar 25, the value is 4.04. This value is within the healthy range. It has decreased from 6.03 (Mar 19) to 4.04, marking a decrease of 1.99.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.02. This value is within the healthy range. It has decreased from 3.91 (Mar 19) to 3.02, marking a decrease of 0.89.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.02. This value is within the healthy range. It has decreased from 3.91 (Mar 19) to 3.02, marking a decrease of 0.89.
• For PBDIT Margin (%), as of Mar 25, the value is 6.45. This value is below the healthy minimum of 10. It has decreased from 7.94 (Mar 19) to 6.45, marking a decrease of 1.49.
• For PBIT Margin (%), as of Mar 25, the value is 4.73. This value is below the healthy minimum of 10. It has decreased from 6.38 (Mar 19) to 4.73, marking a decrease of 1.65.
• For PBT Margin (%), as of Mar 25, the value is 4.22. This value is below the healthy minimum of 10. It has decreased from 4.56 (Mar 19) to 4.22, marking a decrease of 0.34.
• For Net Profit Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 5. It has increased from 2.95 (Mar 19) to 3.14, marking an increase of 0.19.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 8. It has increased from 2.95 (Mar 19) to 3.14, marking an increase of 0.19.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.06. This value is below the healthy minimum of 15. It has decreased from 18.04 (Mar 19) to 10.06, marking a decrease of 7.98.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.28. This value is within the healthy range. It has decreased from 17.52 (Mar 19) to 12.28, marking a decrease of 5.24.
• For Return On Assets (%), as of Mar 25, the value is 5.88. This value is within the healthy range. It has decreased from 6.00 (Mar 19) to 5.88, marking a decrease of 0.12.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 1.01 (Mar 19) to 0.06, marking a decrease of 0.95.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. It has decreased from 1.16 (Mar 19) to 0.09, marking a decrease of 1.07.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 2.01 (Mar 19) to 0.00, marking a decrease of 2.01.
• For Current Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 19) to 1.40, marking an increase of 0.32.
• For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.60 (Mar 19) to 0.67, marking an increase of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 12.71 (Mar 19) to 0.00, marking a decrease of 12.71.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 12.69. This value is within the healthy range. It has increased from 4.18 (Mar 19) to 12.69, marking an increase of 8.51.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.19. This value is within the healthy range. It has increased from 2.51 (Mar 19) to 7.19, marking an increase of 4.68.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,734.64. It has increased from 1,659.83 (Mar 19) to 1,734.64, marking an increase of 74.81.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has decreased from 0.57 (Mar 19) to 0.40, marking a decrease of 0.17.
• For EV / EBITDA (X), as of Mar 25, the value is 6.32. This value is within the healthy range. It has decreased from 7.27 (Mar 19) to 6.32, marking a decrease of 0.95.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 19) to 0.39, marking a decrease of 0.01.
• For Price / BV (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 2.46 (Mar 19) to 1.25, marking a decrease of 1.21.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 19) to 0.39, marking a decrease of 0.01.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 19) to 0.08, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness